Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$32.87 - $43.55 $1.16 Million - $1.54 Million
35,330 Added 32.87%
142,830 $4.78 Million
Q1 2024

May 03, 2024

SELL
$37.88 - $43.77 $147,732 - $170,703
-3,900 Reduced 3.5%
107,500 $4.59 Million
Q4 2023

Feb 02, 2024

BUY
$31.71 - $38.95 $3.17 Million - $3.89 Million
99,900 Added 868.7%
111,400 $4.31 Million
Q3 2023

Nov 13, 2023

BUY
$37.32 - $49.29 $52,248 - $69,006
1,400 Added 13.86%
11,500 $434,000
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $403,797 - $481,568
10,100 New
10,100 $460,000
Q1 2023

May 12, 2023

SELL
$37.58 - $52.57 $108,982 - $152,453
-2,900 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $412,510 - $478,993
-8,300 Reduced 74.11%
2,900 $147,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $21,544 - $26,720
400 Added 3.7%
11,200 $604,000
Q2 2022

Aug 11, 2022

BUY
$63.83 - $80.0 $51,064 - $64,000
800 Added 8.0%
10,800 $694,000
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $768,500 - $894,500
10,000 New
10,000 $775,000
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $611,800 - $668,876
-7,600 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $125,328 - $145,168
1,600 Added 26.67%
7,600 $611,000
Q2 2020

Jul 29, 2020

SELL
$78.66 - $94.14 $204,516 - $244,764
-2,600 Reduced 30.23%
6,000 $516,000
Q4 2019

Feb 18, 2020

BUY
$76.7 - $88.45 $659,620 - $760,670
8,600 New
8,600 $718,000
Q1 2018

May 08, 2018

SELL
$62.56 - $72.26 $218,960 - $252,910
-3,500 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$61.45 - $66.05 $6,145 - $6,605
-100 Reduced 2.78%
3,500 $226,000
Q3 2017

Oct 27, 2017

BUY
$59.5 - $64.61 $214,200 - $232,596
3,600
3,600 $226,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Intact Investment Management Inc. Portfolio

Follow Intact Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.